Novartis Investigative Site

Hatay, Antakya 31101

0 studies enrolling now · 1 studies all time

What they study most

Sickle Cell Disease

Studies at this site

• Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study — Recruiting now